HTRS/X
Jul 10, 2025, 11:23
HTRS Thanks CSL Behring for Its Ongoing Commitment to Research Support
Hemostasis and Thrombosis Research Society (HTRS), has shared a post on X:
“A huge thanks to HTRS Corporate Colleague CSL Behring for committing to support one 2026 Mentored Research Award. Since the 2007 inception of our flagship award program, CSL Behring has funded 12 awards totaling more than $1.5 million. We are grateful for this collaboration.”
Find similar posts on Hemostasis Today.
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS
-
Jun 6, 2026, 06:03Mirriam Akiru: What Does Melena Indicate?
-
Jun 6, 2026, 05:59Eugene Fan: FIBOM-AI – Predicting Marrow Fibrosis From Routine Blood Counts
-
Jun 6, 2026, 05:30Rob Maloney: The Power of Partnership in Bleeding Disorders Care
-
Jun 5, 2026, 20:51Atoosa Salimi: Why Aspirin and Other Antiplatelets Are Not Effective in Preventing Lacunar Ischaemic Stroke
-
Jun 5, 2026, 18:38Annie Bauzon: Clinical Significance and Causes of RBC Anisocytosis
-
Jun 5, 2026, 18:36Nandan Lad: Microclots as the Cause of Secondary Stroke After Subarachnoid Hemorrhage